First half of the year with 1%1 growth at constant exchange rates, significant impact of COVID-19 pandemicGlobeNewsWire • 07/23/20
Phase III data show Roche’s Port Delivery System with ranibizumab enabled over 98% of patients to go six months between treatments for neovascular age-related macular degenerationGlobeNewsWire • 07/22/20
Jnana Therapeutics Enters Collaboration with Roche to Discover Novel Medicines that Target Key Regulators of Cellular Metabolism to Treat Immune-Mediated and Neurological DiseasesBusiness Wire • 07/21/20
PicnicHealth Announces Strategic Partnership with Roche to Generate Scientific Insights from Real World DataBusiness Wire • 07/16/20
Could A $775 Million Roche-Blueprint Deal Unseat Eli Lilly In Cancer?Investors Business Daily • 07/14/20
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancersGlobeNewsWire • 07/14/20
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered CancersPRNewsWire • 07/14/20
New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia AGlobeNewsWire • 07/13/20
Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancerGlobeNewsWire • 07/13/20
Exclusive: EU reaches deals with Roche, Merck for supply of COVID-19 drugs - sourceReuters • 07/08/20
FDA approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancerGlobeNewsWire • 06/29/20
Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia AGlobeNewsWire • 06/29/20
Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorderGlobeNewsWire • 06/29/20
Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithmGlobeNewsWire • 06/26/20
Roche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpointsGlobeNewsWire • 06/19/20
Roche's Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With PneumoniaThe Motley Fool • 06/19/20